Pharmaceuticals 2009, 2(3), 194-205; doi:10.3390/ph2030194

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

1 Unitat de Farmacologia i Farmacognòsia i Institut de Biomedicina (IBUB), Centro de Investigación de Biomedicina en Red de Enfermedades Neurodegenerativas (CIBERNED), Facultat de Farmàcia, Universitat de Barcelona, 08028 Barcelona, Spain 2 Departamento de Biología Celular y Molecular, CUCBA, Universidad de Guadalajara, División de Neurociencias, Centro de Investigación Biomédica de Occidente, IMSS, Sierra Mojada 800, Col. Independencia, Guadalajara, Jalisco 44340, Mexico 3 UMR 975 INSERM, Thérapeutique Expérimentale de la neurodégénérescence, Centre de recherche de l'Institut du cerveau et de la moelle épiniére (CRICM), Université Pierre et Marie Curie, Hôpital de la Salpêtrière, Paris, France 4 Laboratorio de Desarrollo y Regeneración Neural, Instituto de Neurobiología, Departamento de Biología Celular y Molecular, C.U.C.B.A, Universidad de Guadalajara, Guadalajara, Jalisco, México
* Author to whom correspondence should be addressed.
Received: 5 November 2009; in revised form: 2 December 2009 / Accepted: 10 December 2009 / Published: 15 December 2009
(This article belongs to the Special Issue Phytochemicals with actions on the Central Nervous System)
PDF Full-text Download PDF Full-Text [424 KB, uploaded 15 December 2009 10:25 CET]
Abstract: The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NFκβ. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation.
Keywords: resveratrol; Alzheimer’s disease; Parkinson’s disease; SIRT1

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Camins, A.; Junyent, F.; Verdaguer, E.; Beas-Zarate, C.; Rojas-Mayorquín, A.E.; Ortuño-Sahagún, D.; Pallàs, M. Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals 2009, 2, 194-205.

AMA Style

Camins A, Junyent F, Verdaguer E, Beas-Zarate C, Rojas-Mayorquín AE, Ortuño-Sahagún D, Pallàs M. Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals. 2009; 2(3):194-205.

Chicago/Turabian Style

Camins, Antoni; Junyent, Felix; Verdaguer, Ester; Beas-Zarate, Carlos; Rojas-Mayorquín, Argelia E.; Ortuño-Sahagún, Daniel; Pallàs, Mercè. 2009. "Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases." Pharmaceuticals 2, no. 3: 194-205.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert